Advertisement

Did you know that the NovoPen^® 6^† – the latest smart¹ insulin pen from Novo Nordisk – features connectivity with the FreeStyle LibreLink app*?  

The FreeStyle LibreLink app* displays real-time glucose readings taken by the small and discreet FreeStyle Libre 2 sensor, the #1 Continuous Glucose Monitor (CGM) worldwide.^# 

When you transfer your insulin data from the NovoPen^® 6^† to the FreeStyle LibreLink app*, you can easily track insulin doses and get a complete picture of your glucose levels, all in one place. 

Glucose management made even easier with the FreeStyle Libre 2 system. 

Get more out of your glucose management technology in three easy steps: 

Connect 

Transfer your NovoPen^® 6^† insulin dose data into the FreeStyle LibreLink app* in just a few seconds. These doses are automatically recorded in your Logbook – no manual recording required! 

Review 

Track your NovoPen^® 6^† insulin doses and see your FreeStyle Libre 2 sensor glucose trends, all in one place. Easy as. 

Share 

If you are already sharing your FreeStyle LibreLink app* glucose data with your healthcare professional, they will also be able to see your insulin dose data, helping them to refine your treatment plan. 

WATCH NOW: How to securely share your glucose data with your healthcare professional 

Learn more about this update:  

FreeStyleLibre.com.au/NovoPen >  

HAVE YOU HEARD? THE #1 CGM WORLDWIDE^# JUST GOT EVEN BETTER 

With FreeStyle Libre 2, you can now get continuous glucose readings automatically sent to your phone every single minute, without the need to scan.^ 

And it’s free to upgrade and available now! All you have to do is download or update the FreeStyle LibreLink app* on your phone. Your loved ones can also now receive your real-time glucose readings when they download the LibreLinkUp app^‡, for peace of mind when it’s needed most.  

Everything about this update, in one place. 

FreeStyleLibre.com.au/No-Scanning > 

If you’re living with type 1 or type 2 insulin-requiring diabetes, now is the perfect time to experience these new features and upgrade to FreeStyle Libre 2.  

Visit FreeStyleLibre.com.au/Trial and purchase your first sensor for $15.^± Limited time offer! 

TRIAL NOW FOR $15^± > 

FreeStyle Libre 2 is subsidised for Australians living with type 1 diabetes. To learn more and check eligibility criteria, go to FreeStyleLibre.com.au 

ALWAYS FOLLOW THE DIRECTIONS FOR USE. READ THE WARNINGS BEFORE PURCHASE. Find out more at FreeStyleLibre.com.au 

This product is indicated for measuring interstitial fluid glucose levels in people (age 4 and older) with insulin-requiring diabetes. 

† NovoPen^® 6 is a registered trademark owned by Novo Nordisk. The FreeStyle LibreLink app works with FreeStyle Libre 2 sensors and is compatible with NovoPen^® 6. 
* The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check www.freestylelibre.com.au/compatibility for more information about device compatibility before using the app. Use of FreeStyle LibreLink requires registration with LibreView. 

# Data based on the number of users worldwide for FreeStyle Libre family of personal CGMs compared to the number of users for other leading personal CGM brands and based on CGM sales dollars compared to other leading personal CGM brands. 

^ Glucose readings are automatically in the FreeStyle LibreLink app when the sensor has been started with the app, and the smartphone and sensor are connected and in range. Optional scan to backfill up to 8 hours of data following a period of lost sensor connection. 

‡ The LibreLinkUp app is only compatible with certain mobile device and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of LibreLinkUp and FreeStyle LibreLink requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by an app. 

± The FreeStyle Libre 2 ‘$15 Trial Offer’ is a special offer and is only valid in Australia for a limited time. Limit of one $15 sensor per customer. Only available to new FreeStyle Libre 2 customers. Users must be registered and logged into their FreeStyleLibre.com.au account. Click HERE for full Terms & Conditions. 

 
1. Sangave NA, Aungst I U Patel DK. Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology. Diabetes Spectr. 2019 Nov;32(4):378-384. DOI: 10.2337/ds18-0069. PMID: 31798296; PMCID: PMC6858073. 

The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. NovoPen^® 6 is a registered trademark owned by Novo Nordisk. Information contained herein is for distribution outside of the USA only. Abbott Australasia Pty. Ltd., Abbott Diabetes Care, 666 Doncaster Road, Doncaster, Victoria 3108, Australia. ABN 95 000 180 389. ADC-83766 V1.0